Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APDNNASDAQ:BAOSNASDAQ:ISPCNASDAQ:SOPA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPDNApplied DNA Sciences$0.52-1.8%$1.06$0.50▼$177.00$571K0.41441,500 shs375,702 shsBAOSBaosheng Media Group$2.37-2.5%$2.12$1.44▼$13.66$3.63M1.28539,080 shs68,140 shsISPCiSpecimen$1.10-1.8%$1.21$1.02▼$11.80$2.75M1.73407,152 shs44,210 shsSOPASociety Pass$1.39-12.3%$0.99$0.64▼$6.75$6.97M1.451.09 million shs284,389 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPDNApplied DNA Sciences-3.18%-11.76%-37.81%-92.68%-99.47%BAOSBaosheng Media Group+7.52%+4.29%+36.52%-12.59%-29.77%ISPCiSpecimen+4.77%-4.60%-10.32%-38.74%+264.08%SOPASociety Pass+14.39%+37.07%+71.91%+1.92%-14.05%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPDNApplied DNA Sciences1.461 of 5 stars3.52.00.00.02.60.00.0BAOSBaosheng Media Group1.521 of 5 stars0.04.00.00.03.81.70.6ISPCiSpecimen0.8086 of 5 stars0.03.00.00.03.30.80.6SOPASociety Pass2.6904 of 5 stars3.55.00.00.01.60.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPDNApplied DNA Sciences 3.00Buy$75.0014,403.96% UpsideBAOSBaosheng Media Group 0.00N/AN/AN/AISPCiSpecimen 0.00N/AN/AN/ASOPASociety Pass 3.00Buy$15.00979.14% UpsideCurrent Analyst Ratings BreakdownLatest APDN, ISPC, SOPA, and BAOS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/27/2025SOPASociety PassAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$14.00 ➝ $15.004/21/2025SOPASociety PassAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$16.00 ➝ $14.00(Data available from 5/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPDNApplied DNA Sciences$3.79M0.15N/AN/A$0.29 per share1.78BAOSBaosheng Media Group$624.09K5.81N/AN/A$27.60 per share0.09ISPCiSpecimen$8.06M0.34N/AN/A$21.47 per share0.05SOPASociety Pass$6.73M1.03N/AN/A$2.29 per share0.61Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPDNApplied DNA Sciences-$6.99M-$35.85N/A∞N/A-228.12%-101.57%-62.43%8/6/2025 (Estimated)BAOSBaosheng Media Group-$1.85MN/A0.00∞N/AN/AN/AN/AN/AISPCiSpecimen-$11.10M-$12.89N/A∞N/A-91.66%-139.25%-73.97%N/ASOPASociety Pass-$18.13M-$2.85N/AN/AN/A-171.10%-431.98%-79.26%N/ALatest APDN, ISPC, SOPA, and BAOS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025SOPASociety Pass-$0.25-$0.44-$0.19-$0.44$2.20 million$1.47 million5/19/2025Q1 2025ISPCiSpecimenN/A-$0.71N/A-$0.71N/A$1.06 million5/15/2025Q2 2025APDNApplied DNA Sciences-$3.00-$15.35-$12.35-$15.35$1.19 million$0.98 million4/14/2025Q4 2024ISPCiSpecimen-$4.00-$6.28-$2.28-$6.28$2.98 million$1.48 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPDNApplied DNA SciencesN/AN/AN/AN/AN/ABAOSBaosheng Media GroupN/AN/AN/AN/AN/AISPCiSpecimenN/AN/AN/AN/AN/ASOPASociety PassN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPDNApplied DNA SciencesN/A4.724.53BAOSBaosheng Media GroupN/A5.08N/AISPCiSpecimenN/A0.740.74SOPASociety PassN/A0.620.60Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPDNApplied DNA Sciences22.22%BAOSBaosheng Media Group6.34%ISPCiSpecimen13.62%SOPASociety Pass3.09%Insider OwnershipCompanyInsider OwnershipAPDNApplied DNA Sciences0.17%BAOSBaosheng Media Group22.56%ISPCiSpecimen12.20%SOPASociety Pass5.02%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPDNApplied DNA Sciences701.10 million55.10 millionOptionableBAOSBaosheng Media Group1301.53 million1.19 millionNot OptionableISPCiSpecimen602.50 million846,000Not OptionableSOPASociety Pass2,0215.01 million3.44 millionNot OptionableAPDN, ISPC, SOPA, and BAOS HeadlinesRecent News About These CompaniesSociety Pass (SOPA) Expected to Announce Earnings on WednesdayMay 19, 2025 | americanbankingnews.comWhy Society Pass Incorporated (SOPA) Is Soaring This Year So FarFebruary 18, 2025 | msn.comSociety Pass expands stock sale agreementFebruary 14, 2025 | msn.comSociety Pass Inc trading resumesFebruary 12, 2025 | markets.businessinsider.comSociety Pass Inc trading halted, volatility trading pauseFebruary 12, 2025 | markets.businessinsider.comMichael Paul Dunn, Jr. Acquires 12,000 Shares of Society Pass Incorporated (NASDAQ:SOPA) StockFebruary 5, 2025 | insidertrades.comSociety Pass Inc Stock Surges 63%February 4, 2025 | markets.businessinsider.comSociety Pass Inc (SOPA) Stock Surge: The Transparent Factors ExposedFebruary 4, 2025 | bovnews.comBest Momentum Stocks to Buy for January 31stJanuary 31, 2025 | zacks.comNew Strong Buy Stocks for January 31stJanuary 31, 2025 | zacks.comSociety Pass (NASDAQ:SOPA) Stock Quotes, Forecast and News SummaryJanuary 23, 2025 | benzinga.comSociety Pass Inc (SOPA) Stock: More Robust Than the Numbers Suggest?January 22, 2025 | bovnews.comSopa: Tale of the Stolen Potato - Official Trailer | Latin American Games Showcase 2024December 11, 2024 | msn.comSociety Pass Incorporated (SOPA) Reports Q3 Loss, Misses Revenue EstimatesNovember 15, 2024 | zacks.comHollywood director calls out Elon Musk for ‘copying his robots’October 14, 2024 | metro.co.ukThe Correct Order To Watch Psycho-PassSeptember 24, 2024 | msn.com‘Shameless and ugly’: John Lee condemns US bill that could close Hong Kong’s trade offices across AmericaSeptember 17, 2024 | hongkongfp.comSociety Pass Inc (SOPA) Stock Trading RecapAugust 29, 2024 | bovnews.comKeep Colorado Wild Pass Generates Impressive $39.7M for State Parks and Safety Programs in Inaugural YearAugust 26, 2024 | hoodline.comMaxim Group Sticks to Its Hold Rating for Society Pass (SOPA)August 23, 2024 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAPDN, ISPC, SOPA, and BAOS Company DescriptionsApplied DNA Sciences NASDAQ:APDN$0.52 -0.01 (-1.84%) Closing price 04:00 PM EasternExtended Trading$0.52 +0.01 (+1.53%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.Baosheng Media Group NASDAQ:BAOS$2.37 -0.06 (-2.47%) Closing price 04:00 PM EasternExtended Trading$2.44 +0.07 (+3.16%) As of 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Baosheng Media Group Holdings Limited operates as an online marketing solution provider in the People's Republic of China. It connects advertisers, online media, and helping advertisers to manage their online marketing activities in various ways, including advising on advertising strategies, budget, and choice of advertising channels; procures ad inventory; offers ad optimization services; and administrates and fine-tunes the ad placement process. The company also serves media businesses in various ways, including identifying advertisers to buy their ad inventory; facilitating payment arrangements with advertisers; assisting advertisers in handling ad deployment logistics with media; and engaging in other marketing and promotion activities aimed at educating and inducing advertisers to use online advertising. Its advertising services comprise search engine marketing (SEM) services, such as the deployment of ranked search ads and other display search ads offered by search engine operators; and non-SEM services consisting of social media marketing, in-feed advertising, and mobile app advertising through deploying ads on media, such as social media platforms, short-video platforms, news portals, and mobile apps. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.iSpecimen NASDAQ:ISPC$1.10 -0.02 (-1.79%) Closing price 04:00 PM EasternExtended Trading$1.14 +0.04 (+3.64%) As of 05:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.Society Pass NASDAQ:SOPA$1.39 -0.20 (-12.30%) Closing price 04:00 PM EasternExtended Trading$1.39 0.00 (0.00%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Society Pass Incorporated acquires and operates fintech and e-commerce platforms and mobile applications for consumers and merchants in Singapore, Vietnam, Indonesia, Philippines, the United States, Malaysia, Hong Kong, and Thailand. It operates through Online Grocery and Food and Groceries Deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-Commerce, and Merchant Point of Sale segments. The company operates Leflair, an online lifestyle platform that offers services and products, such as fashion and accessories, beauty and personal care, and home and lifestyle; an online food delivery service under the Handycart brand name; and an online grocery delivery service under the Pushkart brand name. It also sells hardware and software to merchant; local mobile phone and global internet data plans; and domestic and overseas air ticket, and global hotel reservations, as well as offers digital marketing services. The company was formerly known as Food Society, Inc. and changed its name to Society Pass Incorporated in October 2018. Society Pass Incorporated was incorporated in 2018 and is headquartered in Singapore. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock GameStop Buys Bitcoin: Smart Strategy or Big Mistake? Qualcomm Stock Turns South: 3 Entry Signals to Watch For D-Wave Quantum Stock: Are Advantage2 Gains Here to Stay? Meta's Institutional & Insider Data Fuels Bulls Despite Disparity Is Michael Burry Right Betting Against the Market Again? Amer Sports: The New ONON and DECK of Consumer Discretionary? BigBear.ai: Risky AI Stock or Defense Tech Opportunity? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
